Condition
Refractory Systemic Lupus Erythematosus clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Refractory Systemic Lupus Erythematosus clinical trials that are recruiting, at sites in 2 countries (most in China (4), Vietnam (1)). By phase: Phase 1 (2), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Refractory Systemic Lupus Erythematosus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| IASO207 injections for active refractory SLE (first-in-human) | Early Phase 1 | Beijing | Recruiting | Jun 1, 2026 |
| Biomarker-guided CAR-T target selection for refractory lupus | Phase 1/2 | Shenzhen, Guangdong | Recruiting | Apr 13, 2026 |
| CD19 CAR-T therapy for refractory lupus in adults | Phase 1 | Hanoi | Recruiting | Feb 25, 2026 |
| Combination treatment for difficult-to-treat lupus | Phase 1 | Guangzhou, Guangdomg | Recruiting | Nov 6, 2024 |
| CAR-T cell therapy for patients with refractory systemic lupus erythematosus | — | Beijing, Beijing Municipality | Recruiting | Jul 22, 2024 |
All recruiting trials (5)
-
IASO207 injections for active refractory SLE (first-in-human)
This early-stage study tests a new in vivo CAR-T therapy called IASO207 to see if it is safe and potentially helpful for adults with active, treatment-resistant SLE.
-
Biomarker-guided CAR-T target selection for refractory lupus
This trial tests whether using a lab-based immune profile to pick CD19- or BCMA-targeted CAR-T can help adults with refractory lupus, including lupus nephritis, who have not responded to standard treatments.
-
CD19 CAR-T therapy for refractory lupus in adults
This trial tests autologous CD19 CAR-T cells to see if they are safe and tolerable for adults with refractory systemic lupus erythematosus.
-
Combination treatment for difficult-to-treat lupus
This study is testing a new combination treatment with NK010 or NK042 and rituximab to see if it helps people with hard-to-treat lupus feel better.
-
CAR-T cell therapy for patients with refractory systemic lupus erythematosus
This study is testing a new CAR-T cell therapy to see if it can help people with hard-to-treat lupus feel better and improve their symptoms.
Related topics
Quick answers
How many Refractory Systemic Lupus Erythematosus clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), Vietnam (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.